Liisa Hantsoo

Liisa Hantsoo

Auto-generated profile, based on publicly available information

Liisa Hantsoo

Department of Psychiatry and Behavioral Sciences, Reproductive Mental Health Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Biological Psychiatry
Verified
Journal Article
Closed access
LHLiisa Hantsoo
Liisa Hantsoo
SKSara Kornfield
Sara Kornfield
MAMontserrat C. Anguera
Montserrat C. Anguera
CEC. Neill Epperson
C. Neill Epperson

1 May 2020 in Neurobiology of Stress
Verified
Journal Article
Open access
LHLiisa Hantsoo
Liisa Hantsoo
CEC. Neill Epperson
C. Neill Epperson
Premenstrual dysphoric disorder (PMDD) is a severe mood disorder with core symptoms (affective lability, irritability, depressed mood, anxiety) and increased sensitivity to stress occurring in the luteal phase of the menstrual cycle. PMDD can be conceptualized as a disorder of suboptimal sensitivity to neuroactive steroid hormones (NASs). In this review, we describe the role of the NAS allopregnanolone (ALLO), a positive allosteric modulator of the GABAA receptor (GABAA-R), in PMDD's pathophysiology. We review evidence of impaired interaction between ALLO and GABAA-Rs in terms of affective symptom expression, with evidence from rodent and human studies. We discuss evidence of increased luteal phase stress sensitivity as a result of poor ALLO-GABA control of the HPA axis. Finally, we describe how treatments such as selective serotonin reuptake inhibitors (SSRIs) and new drugs targeting GABAA-Rs provide evidence for impaired ALLO-GABA function in PMDD. In sum, the literature supports the hypothesis that PMDD pathophysiology is rooted in impaired GABAA-R response to dynamic ALLO fluctuations across the menstrual cycle, manifesting in affective symptoms and poor regulation of physiologic stress response.

1 January 2019 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
LHLiisa Hantsoo
Liisa Hantsoo
EJEldin Jašarević
Eldin Jašarević
SCStephanie Criniti
Stephanie Criniti
BMBrendan McGeehan
Brendan McGeehan
CTCeylan Tanes
Ceylan Tanes
CEC. Neill Epperson
C. Neill Epperson

1 September 2021 in Behavioural Brain Research
Verified
Journal Article
Closed access
LHLiisa Hantsoo
Liisa Hantsoo
BZBabette S. Zemel
Babette S. Zemel

1 July 2018 in Fertility and Sterility
Verified
Journal Article
Closed access
LCLaura G. Cooney
Laura G. Cooney
LMLauren W. Milman
Lauren W. Milman
LHLiisa Hantsoo
Liisa Hantsoo
SKSara Kornfield
Sara Kornfield
MSMary D. Sammel
Mary D. Sammel
ADAnuja Dokras
Anuja Dokras

26 August 2022 in Archives of Women's Mental Health
Verified
Journal Article
Open access
PDF file
LHLiisa Hantsoo
Liisa Hantsoo
SRShivani Rangaswamy
Shivani Rangaswamy
KVKristin Voegtline
Kristin Voegtline
RSRodion Salimgaraev
Rodion Salimgaraev
LZLiudmila Zhaunova
Liudmila Zhaunova
JPJennifer L. Payne
Jennifer L. Payne
Premenstrual symptoms, including physical and mood symptoms, affect a large proportion of women worldwide. Data on premenstrual symptoms across nations and age groups is limited. In the present study, we leveraged a large international dataset to explore patterns in premenstrual symptom frequency with age. A survey was administered to users of the Flo mobile application (app), aged 18 to 55. The survey queried app users about a range of premenstrual symptoms. Respondents were asked whether they experienced each symptom every menstrual cycle, some cycles, or never. Age was also captured and categorized as 18–27, 28–37, 38–47, 48–55. Data was summarized and Pearson’s chi square test for count data assessed differences in symptom frequency by age group. A sample of 238,114 app users from 140 countries responded to the survey. The most common symptoms reported were food cravings (85.28%), mood swings or anxiety (64.18%), and fatigue (57.3%). Absentmindedness, low libido, sleep changes, gastrointestinal symptoms, weight gain, headaches, sweating or hot flashes, fatigue, hair changes, rashes, and swelling were significantly more frequent with increasing age (p’s < 0.001). Mood swings and anxiety did not vary by age group. Of the respondents, 28.61% reported that premenstrual symptoms interfered with their everyday life each menstrual cycle. In a large international sample, the majority of women reported premenstrual food cravings, mood changes, and fatigue every menstrual cycle. Mood symptoms did not vary by age group, suggesting that premenstrual mood changes are a persistent issue among women of reproductive age.